MedPath

Magnesium citrate

Generic Name
Magnesium citrate
Brand Names
Citroma
Drug Type
Small Molecule
Chemical Formula
C12H10Mg3O14
CAS Number
3344-18-1
Unique Ingredient Identifier
RHO26O1T9V

Overview

Magnesium citrate is a low volume and osmotic cathartic agent. The cathartic action works primarily through the high osmolarity of the solution which draws large amounts of fluid into space where is used. Magnesium citrate is considered by the FDA as an approved inactive ingredient for approved drug products under the specifications of oral administration of a maximum concentration of 237 mg. It is also considered as an active ingredient in over-the-counter products.

Background

Magnesium citrate is a low volume and osmotic cathartic agent. The cathartic action works primarily through the high osmolarity of the solution which draws large amounts of fluid into space where is used. Magnesium citrate is considered by the FDA as an approved inactive ingredient for approved drug products under the specifications of oral administration of a maximum concentration of 237 mg. It is also considered as an active ingredient in over-the-counter products.

Indication

Magnesium citrate has been used in bowel preparations prior to a colonoscopy as a cathartic agent. It is also used in over-the-counter products to relieve occasional constipation. Magnesium citrate can be one of the forms used for the administration of dietary supplements.

Associated Conditions

  • Migraine

Research Report

Published: May 13, 2025

Magnesium Citrate Report

Name: Magnesium citrate Name (English): Magnesium citrate DrugBank ID: DB11110 Type: Small Molecule CAS Number: 3344-18-1

Magnesium citrate is a magnesium salt of citric acid with the molecular formula $\text{C}{12}\text{H}{10}\text{Mg}3\text{O}{14}$ and a molecular weight of 451.113 g/mol. It may exist as an anhydrous or hydrated salt.

Pharmacology: Magnesium citrate is an osmotic laxative that works by increasing fluid in the small intestine, which stimulates bowel movements. The high osmolality of the solution draws large amounts of fluid into the colonic lumen. It may also stimulate fluid excretion by cholecystokinin release and activation of muscle peristalsis. Magnesium is also an essential mineral involved in numerous enzymatic reactions and physiological processes.

Indications:

  • Bowel preparation before medical procedures like colonoscopy.
  • Relief of occasional constipation.
  • Magnesium supplementation for the treatment or prevention of hypomagnesemia.

Dosage & Administration: Dosage varies depending on the indication and patient age. For constipation in adults, 195-300 mL of oral solution in a single daily dose or divided doses with a full glass of water, or 2-4 tablets at bedtime. For bowel preparation, a healthcare professional will provide specific instructions. As a nutritional supplement, the recommended daily allowance for magnesium varies by age and sex.

Contraindications:

  • Bowel obstruction or perforation
  • Ileus
  • Severe abdominal pain
  • Nausea or vomiting
  • Rectal bleeding
  • Kidney disease

Adverse Effects: Common side effects include abdominal discomfort, cramping, gas, and nausea. More serious side effects may include persistent diarrhea, severe abdominal pain, slow or irregular heartbeat, mental or mood changes, muscle weakness, and dehydration.

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2021/08/24
Phase 3
Recruiting
2021/06/18
N/A
Withdrawn
2014/01/09
Phase 3
Completed
Professor Fernando Figueira Integral Medicine Institute

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
PureTek Corporation
59088-795
ORAL
16 mg in 1 1
9/14/2023
PUBLIX SUPER MARKETS, INC.
56062-266
ORAL
1.745 g in 29.6 mL
6/23/2025
PureTek Corporation
59088-660
ORAL
33.33 mg in 1 mL
12/18/2023
CVS Pharmacy
69842-763
ORAL
1.745 g in 29.6 mL
5/21/2025
UpLift Brands, LLC
83986-166
ORAL
1.745 g in 29.6 mL
5/12/2025
Rite Aid
11822-4330
ORAL
1.745 g in 29.6 mL
6/23/2025
UpLift Brands, LLC
83986-162
ORAL
1.745 g in 29.6 mL
5/12/2025
UpLift Brands, LLC
83986-164
ORAL
1.745 g in 29.6 mL
5/12/2025
OLD EAST MAIN CO
55910-183
ORAL
1.745 g in 29.6 mL
6/9/2025
PUBLIX SUPER MARKETS, INC.
56062-264
ORAL
1.745 g in 29.6 mL
6/23/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

© Copyright 2025. All Rights Reserved by MedPath